Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1825 of 3546 entries
View as:

Evaluation of Plaque Fluid Fluoride Retention From Fluoride Toothpastes

Phase: N/A Priority: Normal
NCT ID: NCT00708305 Org: User:
Start: 06/30/08 End: 10/31/08 Due: 10/31/09

A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline Biologicals' Influenza Vaccine GSK3206641A Administered in Adults 18 to 64 Years of Age and 65 Years of Age and Older

Phase: N/A Priority: Normal
NCT ID: NCT04789577 Org: User:
Start: 03/16/21 End: 09/12/22 Due: 09/12/23

Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01051063 Org: User:
Start: 12/09/09 End: 04/26/16 Due: 04/26/17

A Study to Evaluate the Safety of GSK2398852 When Co-administered With GSK2315698 in Patients With Systemic Amyloidosis

Phase: N/A Priority: Normal
NCT ID: NCT01777243 Org: User:
Start: 05/13/13 End: 12/22/15 Due: 12/22/16

Effect Of Rilapladib (SB-659032) On Platelet Aggregation

Phase: N/A Priority: Normal
NCT ID: NCT00387257 Org: User:
Start: 10/31/06 End: 04/30/07 Due: 04/30/08

Modulation of Abeta Levels by GSK933776 in Alzheimer's Disease Patient

Phase: N/A Priority: Normal
NCT ID: NCT01424436 Org: User:
Start: 05/19/10 End: 12/08/11 Due: 12/08/12

Sero-prevalence of Anti-pertussis Antibodies and Disease Awareness Among Spanish Healthcare Professionals

Phase: N/A Priority: Normal
NCT ID: NCT01706224 Org: User:
Start: 11/30/12 End: 05/31/13 Due: 05/31/14

Clinical Evaluation of BRL29060A (Paroxetine Hydrochloride Hydrate) in Posttraumatic Stress Disorder (PTSD)

Phase: N/A Priority: Normal
NCT ID: NCT00557622 Org: User:
Start: 01/25/08 End: 12/11/08 Due: 12/11/09

Study to Investigate the Irritation Potential of GSK1940029 Gel

Phase: N/A Priority: Normal
NCT ID: NCT01984801 Org: User:
Start: 10/14/13 End: 04/10/15 Due: 04/10/16

Reacto & Immunogenicity of TF Formulation of Influsplit SSW® 2002/03 v/s Std Formulation of Influsplit SSW® 2002/03

Phase: N/A Priority: Normal
NCT ID: NCT00731029 Org: User:
Start: 09/30/02 End: - Due: -

A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector

Phase: N/A Priority: Normal
NCT ID: NCT02124798 Org: User:
Start: 05/20/14 End: 04/13/15 Due: 04/13/16

Chlorproguanil-Dapsone-Artesunate Versus COARTEM For Uncomplicated Malaria

Phase: N/A Priority: Normal
NCT ID: NCT00344006 Org: User:
Start: 06/30/06 End: 08/31/07 Due: 08/31/08

Oral Topotecan Versus Intravenous Docetaxel In Pretreated, Advanced Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00049998 Org: User:
Start: 10/31/01 End: - Due: -

First Time in Human Study (FTIH) With Positron Emission Tomography (PET)

Phase: N/A Priority: Normal
NCT ID: NCT01381419 Org: User:
Start: 10/20/08 End: 04/01/09 Due: 04/01/10

Immunogenicity and Safety of BoostrixTM Using a New Syringe in 10 to 15-year Old Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT01362322 Org: User:
Start: 07/01/11 End: 09/03/12 Due: 09/03/13

A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT01009463 Org: User:
Start: 09/25/09 End: 10/31/11 Due: 10/31/12

Evaluation of Immunogenicity and Safety of Two Formulations of GSK Biologicals' Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks

Phase: N/A Priority: Normal
NCT ID: NCT02914184 Org: User:
Start: 10/27/16 End: 11/26/18 Due: 11/26/19

A Study To Test The Effect Of GW786034 (Pazopanib) On P450 Enzymes

Phase: N/A Priority: Normal
NCT ID: NCT00401583 Org: User:
Start: 07/28/06 End: 02/20/08 Due: 02/20/09

Study of Pazopanib and Pemetrexed in Advanced Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00871403 Org: User:
Start: 07/31/09 End: 03/31/11 Due: 03/31/12

A Phase I Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of GSK2118436 in Subjects With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00880321 Org: User:
Start: 06/04/09 End: 03/20/12 Due: 03/20/13

Comparative Study of Error Rates Between ELLIPTA® Dry Powder Inhaler (DPI) and Other DPIs

Phase: N/A Priority: Normal
NCT ID: NCT03114969 Org: User:
Start: 06/08/17 End: 03/09/18 Due: 03/09/19

Immunogenicity and Safety Study of FluarixTM Vaccine in Children Who Have Previously Been Vaccinated With PandemrixTM

Phase: N/A Priority: Normal
NCT ID: NCT01190215 Org: User:
Start: 10/04/10 End: 07/07/11 Due: 07/07/12

A Study of GSK2981278 Ointment in Subjects With Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT03004846 Org: User:
Start: 02/13/17 End: 05/05/17 Due: 05/05/18

Characterisation of T-cell Response to Keyhole Limpet Hemocyanin (KLH) and Tuberculin Purified Protein Derivative (PPD)

Phase: N/A Priority: Normal
NCT ID: NCT01910662 Org: User:
Start: 02/22/13 End: 11/26/13 Due: 11/26/14

Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older

Phase: N/A Priority: Normal
NCT ID: NCT00979602 Org: User:
Start: 11/09/09 End: 02/01/11 Due: 02/01/12